Trial Profile
Clinical outcomes of everolimus- versus zotarolimus-eluting stent in patients with coronary chronic occlusions
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 Feb 2017
Price :
$35
*
At a glance
- Drugs Everolimus (Primary) ; Zotarolimus (Primary)
- Indications Coronary artery disease
- Focus Therapeutic Use
- 21 Feb 2017 New trial record